Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 98, Issue 1, 2004, Pages 57-65

  Tzanakis, Nikolaos ^a   Chrysofakis, Georgios ^a   Tsoumakidou, Maria ^a   Kyriakou, Despina ^a   Tsiligianni, Joanna ^a   Bouros, Demosthenes ^a   Siafakas, Nikolaos ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

CD8+; Chronic obstructive; COPD; IL4; Inflammation; INF ; Pathogenesis; Pulmonary disease; Smoking; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SMOKING HABIT; SPIROMETRY; SPUTUM CYTODIAGNOSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 0346505456     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.08.007     Document Type: Article

References (30)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163:1256-76.
2. Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma giles F. Filley lecture. Chest 2000;117:251 S-60S.
3. + T-tymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822-6.
4. Lams BE, Sousa AR, Rees PJ, Lee TH. Subepithetial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512-6.
5. 1. Am J Respir Crit Care Med 1997;155:852-7.
6. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12-8.
7. Hoser G, Kawiak J, Domagala-Kutawik J, Kopinski P, Droszcz W. Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol 1999;37:25-30.
8. de Jong JW, van der Belt-Gritter B, Koeter GH, Postma DS. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IGE and lung function. Respir Med 1997;91: 67-76.
9. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999;103:458-62.
10. + Th2 lymphocytes in the development of smoking-related lung damage. Biochemical and Biophysical Research Communications 1997;239:146-9.
11. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force [see comments]. Eur Respir J 1995;8:1398-420.
12. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coat Official Statement of the European Respiratory Society (see comments). Eur Respir J Suppl 1993;16:5-40.
13. Kips JC, Peleman RA, Pauwels RA. Methods of examining induced sputum: do differences matter? Eur Respir J 1998; 11:529-33.
14. Kyriakou D, Liapi D, Kyriakou E, Alexandrakis M, Vlachonikolis IG, Mavromanotakis M, et al. Aberrant expression of the major sialoglycoprotein (CD43) on the monocytes of patients with myelodysplastic syndromes. Ann Hematol 2000;79: 198-205.
15. Conover WJ. Practical nonparametric statistics. In: Conover WJ, editor. Practical nonparametric statistics. New York: Wiley; 1999. p. 1999.
16. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001;46:798-825.
17. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Core Med 1999;160:S17-20.
18. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-9.
19. + T cells. Int Arch Allergy Immunol 1995;107:354-5.
20. Hagendorens MM, Van Bever HP, Schuerwegh AJ, De Clerck LS, Bridts CH, Stevens WJ. Determination of T-cell subpopulations and intracellular cytokine production (interleukin-2, interleukin-4, and interferon-gamma) by cord blood T-tymphocytes of neonates from atopic and non-atopic parents. Pediatr Allergy Immunol 2000; 11:12-9.
21. Inui N, Chida K, Suda T, Nakamura H. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 2001;107:337-44.
22. Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001;164:S71-5.
23. Cannon MJ, Openshaw PJ, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988;168: 1163-8.
24. + cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995; 181:1229-33.
25. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995;1:1279-83.
26. Clementi M, Forabosco P, Amadori A, Zamarchi R, De Silvestro G, Di Gianantonio E, et al. CD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genes. Hum Genet 1999;105:337-42.
27. Erard F, Wild MT, Garcia-Sanz JA, Le Gros G. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. Science 1993;260:1802-5.
28. Carter LL, Dutton RW. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996;8:336-42.
29. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-80.
30. Cosio MG, Majo J. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002;121: 160S-5S.